In the first of a two-part series about Hong Kong’s market for initial public offerings, Zhang Shidong and Ao Yulu report that more Chinese companies opted to list in Hong Kong in the first eight months of 2025 than in New York. Hong Kong has overtaken the US as the new listing venue for Chinese…
Wuxi AppTec, Asia’s largest provider of contract pharmaceutical research, has raised HK$7.70 billion (US$981 million) through a sale of additional shares in Hong Kong as it rides the wave of bullish appetite for Chinese biotechnology shares. The Shanghai-based company sold 73.8 million new shares to institutional investors at HK$104.27 each, a 6.9 per cent discount…
Wuxi AppTec, Asia’s largest provider of contract pharmaceutical research, has raised HK$7.70 billion (US$981 million) through a sale of additional shares in Hong Kong as it rides the wave of bullish appetite for Chinese biotechnology shares. The Shanghai-based company sold 73.8 million new shares to institutional investors at HK$104.27 each, a 6.9 per cent discount…
Shareholders of mainland Chinese companies are showing increasing interest in setting up family offices in Hong Kong after their initial public offerings amid a swelling pipeline of new listings in the city, according to an asset manager overseeing up to US$2 billion in wealth. “This week alone, I have met two clients inquiring about family…
Chinese heating systems supplier Zhejiang Sanhua Intelligent Controls had a tepid trading debut in Hong Kong on Monday, with investors selling shares following the initial public offering (IPO) frenzy. Trading under the code 2050, the stock began trading at HK$20.95 amid a declining market, 7.2 per cent lower than its offer price of HK$22.53, in…
Foshan Haitian Flavouring and Food Company, the largest listed condiment producer in mainland China, is seeking to raise up to HK$9.56 billion (US$1.22 billion) in Hong Kong, marking one of the city’s largest initial public offerings (IPOs) this year and giving a boost to its status as a world-leading fundraising hub. The company is offering…
A 17 per cent surge since its listing last month has propelled CATL’s Hong Kong-traded shares (H shares) to an 11 per cent premium over their mainland-listed counterparts (A shares), a rarity among the 155 dual-listed companies. And the Hong Kong-listed shares of Hengrui, China’s biggest drug maker by market value, are now nearly on…
Hong Kong’s market for initial public offerings (IPOs) has come roaring back. Attractive valuations, strong liquidity and supportive government policies, what’s not to like? Concerns about geopolitical tensions and a trade war have taken a back seat, at least for now. Certainly, a 90-day truce in the tit-for-tat tariffs battle between China and the United…